Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,620
-$52,688 QoQ
Shares Held
27,024
-7.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 161 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names. HRTX ranks #173 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in HRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,620 | 27,024 | Shares | Defined | 2026-08-14 | |
| 2025-03-31 | $64,308 | 29,231 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $849,365 | 426,817 | Shares | Defined | 2024-11-12 | |
| 2023-12-31 | $339,843 | 199,908 | Shares | Defined | 2024-02-09 | |
| 2023-03-31 | $826,521 | 547,365 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,098,460 | 439,384 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,605,461 | 380,441 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $343,854 | 37,662 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||